Hongbo Pharmaceutical: Shareholders are inquiring about transferring 6.9793 million shares at a price of 25.27 yuan per share.

Hongbo Pharmaceuticals announcement, as of December 25, 2025 inquiry subscription shows that the initial price of the shareholder inquiry transfer is 25.27 yuan per share. 24 institutions effectively subscribed for 13.878 million shares, with an effective subscription ratio of 1.99 times; it is planned to transfer 6.9793 million shares have been fully subscribed, and 20 institutions have been preliminarily determined as transferees. This transfer will not be conducted through centralized bidding or block trading. After the transferee has received the shares, they are not allowed to transfer them within 6 months.